Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro

Erickson-Miller, C. L., May, Richard D., Tomaszewski, Joseph, Osborn, Blaire, Murphy, Martin J., Page, John G., Parchment, Ralph E.·1997·Cancer Chemotherapy and Pharmacology

Cited by (111)

Items 101–111 of 111

  1. PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67
    Eleftheria Tsakalozou · 2013 · UKnowledge (University of Kentucky)
  2. Radiation Worker Protection by Exposure Scheduling
    R. Blankenbecler · 2011 · Dose-Response
  3. In Vitro and Ex Vivo Evaluation of Hematopoietic System
    Wenyue Hu, E. Clarke · 2017 · Elsevier eBooks
  4. Chapter 14: Camptothecin in Sterically Stabilized Phospholipid Micelles: A Novel Nanomedicine
    Chung-Hao Wang, Shih-Hwa Chiou, Chen-Pin Chou, Yu-Chih Chen, Yao-Jhang Huang, Ching-An Peng · 2017 · CRC Press eBooks
  5. Topoisomerase I inhibitors and drug resistance
    Ralph E. Parchment, Augusto Pessina · 1998 · Springer eBooks
  6. Response
    Clinton F. Stewart, Peter J. Houghton · 1998 · JNCI Journal of the National Cancer Institute
  7. Refinement and verification of test conditions for colony-forming unit assay in dog bone marrow cells with preservable colony specimens
    Kazuhiko Takamatsu, Akihiro Wakata, Rika Hirota, Hajime Tabata, Takahito Nishikata · 2013 · Comparative Clinical Pathology
  8. Models for Studying the Action of Topoisomerase-I Targeted Drugs
    Joyce Thompson, Clinton F. Stewart, Peter J. Houghton · 2002 · Humana Press eBooks
  9. In Vitro and Ex Vivo Evaluation of Hematopoietic System
    W. HuWenyue, E. Clarkeemer · 2018 · Elsevier eBooks
  10. Stabilized phospholipid-topotecan prodrug particles increase vascular permeability and ultrasound-enhanced neuroblastoma delivery
    Mendi Marquez, Fernando Flores-Guzmán, Isabella J. Iwanicki, Lydia L. Wu, Jacky Gomez-Villa, Paula Viza-Gomes, Rachael M. Sundland, Mohammadaref Ghaderi, Liliya V. Frolova, Shashank Ramesh Sirsi et al. · 2026 · International Journal of Pharmaceutics
  11. Bone Marrow as a Critical Normal Tissue that Limits Drug Dose/Exposure in Preclinical Models and the Clinic
    Ralph E. Parchment · 2010 · Humana Press eBooks